| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
4 companies
Robert McNamara is Director at XTNT and has filed Form 4s across 4 companies. Robert McNamara's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $1.9M at current prices.
Historically, Robert McNamara's trades have earned a below-average insider score of 42/100 across 4 rated trades. Over a 12-month horizon, 50.0% of those trades were profitable, with an average 12-month return of +26.5%.
The biggest single holding is RCEL (~$1.3M) as Director. Net of sales, the RCEL filings show accumulation of 41,000 shares.
Robert McNamara has 19 Form 4 filings on record from May 2018 to June 2026, across 4 companies: Director at AVITA Medical (AVHHL), 2026; Director at AVITA Medical (RCEL), 2023–2025; Director at Xtant Medical (XTNT), 2018–2024, and 1 more.
The 29 reported transactions were 15 stock awards, 7 option or other derivative awards, 4 open-market purchases and 3 dispositions back to the company.
Counted by filing, the open-market trades come to 4 purchases worth about $287K and no sales.
The largest open-market purchase was 10,000 shares of RCEL at an average $10.09 on February 20, 2025, about $101K. Twelve months later RCEL was down 52%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Aug 28, 2025 | RCEL Avita Medical, Inc. | Director | Buy | 10,000 | $4.50 | $45,000.00 | +13.0% | -10.7% | +136.3% | |
| Aug 19, 2025 | RCEL Avita Medical, Inc. | Director | Buy | 10,000 | $5.00 | $50,000.00 | +15.0% | -20.7% | +112.3% | |
| Mar 6, 2025 | RCEL Avita Medical, Inc. | Director | Buy | 11,000 | $8.30 | $91,300.00 | +24.0% | -28.3% | -42.3% | |
| Feb 20, 2025 | RCEL Avita Medical, Inc. | Director | Buy | 10,000 | $10.09 | $100,900.00 | +28.0% | -34.5% | -51.9% |